|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Spinocerebellar Ataxia | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Ataxia | |||||
| Spinocerebellar Ataxias | |||||
| 3 | More general conditions related to this trial | ||||
| Brain Diseases | |||||
| Central Nervous System Diseases | |||||
| Cerebellar Ataxia | |||||
| Cerebellar Diseases | |||||
| Dyskinesias | |||||
| Genetic Diseases, Inborn | |||||
| Heredodegenerative Disorders, Nervous System | |||||
| Nervous System Diseases | |||||
| Neurodegenerative Diseases | |||||
| Neurologic Manifestations | |||||
| Signs and Symptoms | |||||
| Spinal Cord Diseases | |||||
| Spinocerebellar Degenerations | |||||
| 4 | Sponsors listed in this trial | ||||
| University of Mississippi Medical Center | |||||
| University of Texas | |||||